Free shipping on all orders over $ 500

MRT199665 

Cat. No. M28491

All AbMole products are for research use only, cannot be used for human consumption.

MRT199665  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

MRT199665 is a potent and ATP-competitive, selective MARK/SIK/AMPK inhibitor with IC50s of 2/2/3/2 nM, 10/10 nM, and 110/12/43 nM for MARK1/MARK2/MARK3/MARK14, AMPKα1/AMPKα2, and SIK1/SIK2/SIK3, respectively. MRT199665 causes apoptosis in MEF2C-activated human acute myeloid leukemias (AML) cells. MRT199665 inhibits the phosphorylation of SIK substrate CRTC3 at S370.

Chemical Information
Molecular Weight 469.58
Formula C28H31N5O2
CAS Number 1456858-57-3
Form Solid
Solubility (25°C) DMSO 125 mg/mL (ultrasonic)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Mingsong Shi, et al. Phys Chem Chem Phys. Exploring the stability of inhibitor binding to SIK2 using molecular dynamics simulation and binding free energy calculation

[2] Luke D Hutchinson, et al. Cell Death Dis. Salt-inducible kinases (SIKs) regulate TGFβ-mediated transcriptional and apoptotic responses

[3] Fiona C Brown, et al. Cancer Discov. MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia

[4] Fiona A Ross, et al. Cell Chem Biol. Mechanisms of Paradoxical Activation of AMPK by the Kinase Inhibitors SU6656 and Sorafenib

[5] Nicola J Darling, et al. Biochem J. Inhibition of SIK2 and SIK3 during differentiation enhances the anti-inflammatory phenotype of macrophages

Related Salt-inducible Kinase Products
SIKs-IN-1

SIKs-IN-1 inhibitor.

MR22

MR22 is a potent pan-SIK (salt-inducible kinase) inhibitor.

SIK2-IN-1

SIK2-IN-1 is a potent SIK2 inhibitor over other AMPK kinases.

GLPG3970

GLPG3970 is a first-in-class salt-inducible kinase SIK2/SIK3 inhibitor for studies related to inflammatory and autoimmune diseases such as psoriasis.

YKL-06-062 

YKL-06-062 is a second-generation salt-inducible kinase (SIK) inhibitor with an IC50 of 2.12 nM/1.40 nM/2.86 nM for SIK1, SIK2 and SIK3, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: MRT199665  supplier, Salt-inducible Kinase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.